Adamis Pharmaceuticals (ADMP) Get a 'Buy' Recommendation

Adamis Pharmaceuticals (ADMP) got a 'Buy' recommendation yesterday (02014.01.28) by some research firm named CRT Capital. The 'Buy' recommendation took place prior the market opening. ADMP had a gap open at $7.10 after a previous close of $6.68. The $7.10 ended up being the intra-day high and ADMP closed at $6.81. Volume was 7.4-times the trailing-3-month average. ADMP is up 100% from its 52-week low of $3.40, but it's still well below it's 52-week high of $17.17.